Cadrenal Therapeutics, Inc.
CVKD
$1.19
-$0.01-0.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -3.32M | -2.50M | -3.04M | -2.69M | -3.67M |
| Total Depreciation and Amortization | 500.00 | 600.00 | 600.00 | 400.00 | 400.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 672.10K | 252.40K | 325.10K | 473.40K | 592.60K |
| Change in Net Operating Assets | 416.80K | -758.60K | 143.40K | -145.20K | 48.40K |
| Cash from Operations | -2.23M | -3.00M | -2.57M | -2.36M | -3.03M |
| Capital Expenditure | -- | -- | 0.00 | -1.90K | 0.00 |
| Sale of Property, Plant, and Equipment | 1.40K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 1.40K | -- | 0.00 | -1.90K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 91.60K | 1.37M | 3.10M | 684.00K | 1.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.22M | -64.00K | -378.50K | -35.60K | -63.70K |
| Cash from Financing | 2.31M | 1.30M | 2.72M | 648.40K | 1.26M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.00K | -1.70M | 147.70K | -1.71M | -1.77M |